What are the recommended antihistamines and dosing for infants and children with allergic conditions?

Antihistamine Use in Children and Infants

For infants and children with allergic conditions, use second-generation antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, or loratadine) rather than first-generation antihistamines, and avoid all over-the-counter cough and cold antihistamine products in children below 6 years of age.

Critical Safety Distinction

The evidence draws a sharp line between two classes of antihistamines in pediatric populations:

First-Generation Antihistamines (AVOID in children <6 years)

• Between 1969-2006, there were 69 pediatric fatalities associated with first-generation antihistamines (diphenhydramine, brompheniramine, chlorpheniramine), with 41 deaths occurring in children under age 2 1
• Deaths resulted from overdose errors, use of multiple products, medication errors, and accidental exposures
• The FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended in 2007 that OTC cough and cold medications (containing these antihistamines) should not be used in children below 6 years 1

Second-Generation Antihistamines (SAFE and EFFECTIVE)

These are the recommended agents for pediatric allergic conditions:

• Cetirizine
• Desloratadine
• Fexofenadine
• Levocetirizine
• Loratadine

These medications have been shown to be well tolerated with an excellent safety profile when used in young children 1

Age-Specific Recommendations

Infants (6-11 months)

• Cetirizine is safe at 0.25 mg/kg twice daily (mean dose ~4.5 mg/day) 2
• This is the only antihistamine with prospective, randomized, double-blind, placebo-controlled safety data in infants
• No cardiac QT prolongation or increased adverse events compared to placebo
• Licensed in the USA for infants ≥6 months 3

Children 2-6 years

• Second-generation antihistamines are safe and effective
• Cetirizine licensed in Europe for children ≥2 years 3
• Avoid all first-generation antihistamines and OTC combination products

Children >6 years

• All second-generation antihistamines are appropriate
• First-generation antihistamines may be used with caution if specifically indicated (e.g., bedtime sedation desired), but second-generation agents remain preferred 1

Clinical Context: When to Use Antihistamines

Primary Indications

• Allergic rhinitis: Oral antihistamines or intranasal antihistamines for mild disease or rapid symptom relief 4
• Chronic spontaneous urticaria: Second-generation antihistamines are first-line 5, 3
• Allergic conjunctivitis: Oral or ocular antihistamines 5
• Atopic eczema: May provide benefit for pruritus 5

Important Limitations

• NOT effective for upper respiratory infections in young children—controlled trials show antihistamine-decongestant combinations do not work for URI symptoms 1
• NOT recommended for asthma treatment in children with allergic rhinitis and asthma (though may still treat rhinitis symptoms) 6
• NOT first-line for moderate-severe allergic rhinitis—intranasal corticosteroids are more effective 1, 4

Treatment Algorithm for Pediatric Allergic Rhinitis

1. Mild disease or need for rapid relief: Start second-generation oral antihistamine or intranasal antihistamine
2. Moderate-severe disease: Intranasal corticosteroids are first-line (more effective than antihistamines) 1, 4
3. Inadequate control with intranasal corticosteroids: Add intranasal antihistamine (NOT oral antihistamine—combination provides no additional benefit) 4
4. Seasonal predictable disease: Start intranasal corticosteroids 1-2 weeks before pollen season 4

Critical Pitfalls to Avoid

• Never use OTC cough/cold products containing antihistamines in children <6 years—high risk of fatal overdose 1
• Do not combine multiple antihistamine-containing products—this was a common cause of fatal overdoses 1
• Do not add oral antihistamines to intranasal corticosteroids expecting better control—evidence shows no clinically meaningful benefit 4
• Do not use antihistamines to treat asthma symptoms—they are ineffective for this purpose 6

Specific Dosing Considerations

Renal Impairment

• Halve the dose of cetirizine, levocetirizine, and hydroxyzine in moderate renal impairment
• Avoid cetirizine and levocetirizine in severe renal impairment (creatinine clearance <10 mL/min) 7

Hepatic Impairment

• Use caution with most antihistamines in significant hepatic disease 7

Pregnancy/Lactation

• Avoid all antihistamines when possible, especially first trimester
• If necessary, chlorphenamine has longest safety record, though loratadine and cetirizine are FDA Pregnancy Category B 7